Anti-HPV31 Major capsid protein L1 Antibody (5F12)

Catalog No.

RVV19501

Species reactivity

Human papillomavirus 31 (HPV31)

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Target

L1, Major capsid protein L1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P17388

Applications

ELISA-cap, Neutralization

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

5F12

The Synthesis of Main Capsid Protein of Anogenital Type HPV6 L1 in Plant Expression System on the Basis of Tomato Fruits., PMID:34189649

Worldwide genetic variations in high-risk human papillomaviruses capsid L1 gene and their impact on vaccine efficiency., PMID:33636291

Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes., PMID:32967963

Displaying 31RG-1 peptide on the surface of HPV16 L1 by use of a human papillomavirus chimeric virus-like particle induces cross-neutralizing antibody responses in mice., PMID:29683766

Robust In Vitro and In Vivo Neutralization against Multiple High-Risk HPV Types Induced by a Thermostable Thioredoxin-L2 Vaccine., PMID:26170394

Naturally Occurring Capsid Protein Variants of Human Papillomavirus Genotype 31 Represent a Single L1 Serotype., PMID:25995264

Pre-clinical immunogenicity of human papillomavirus alpha-7 and alpha-9 major capsid proteins., PMID:25203446

A three component mix of thioredoxin-L2 antigens elicits broadly neutralizing responses against oncogenic human papillomaviruses., PMID:24662712

Amino acid sequence diversity of the major human papillomavirus capsid protein: implications for current and next generation vaccines., PMID:23722024

Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes., PMID:21346798

Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications., PMID:19533761

Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31., PMID:16508703

Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies., PMID:16254978

Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1., PMID:14557648

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses., PMID:12050360

A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16., PMID:8133532

Document Download

Anti-HPV31 Major capsid protein L1 Antibody (5F12).pdf